FILING ANALYSIS · WEDNESDAY, NOVEMBER 4
LEMAITRE VASCULAR INC LMAT — 8-K: Results of Operations and Financial Condition
positive
LeMaitre Vascular reported Q3 sales of $68.0mm, an 11% increase year-over-year, and provided guidance for Q4 and full-year 2026, with expected sales growth of 10-11% and EPS growth of 7-11%.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →